P3 Health Partners Inc.
PIIINASDAQHealthcare● Active
$12.25
+$0.67(+5.79%)
Market Cap$40352554
P/E Ratio—
52W High$16.89
52W Low$1.52
P3 Health Partners Inc. (PIII) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PIII · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$0.99
Est. -$4.85 · +79.6%
Revenue
$0.39B
Est. $0.39B · -1.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
PIII reports quarterly as a NASDAQ-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$1.90 | — | — | — | $0.38B | — |
| ▲ Q2 FY2026 | May 14, 2026 | -$4.85 | -$0.99 | +79.6% | $0.39B | $0.39B | -1.3% |
| ▼ Q1 FY2026 | Mar 26, 2026 | -$8.06 | -$23.02 | -185.5% | $0.38B | $0.35B | +8.8% |
| ▼ Q4 FY2025 | Nov 14, 2025 | -$5.29 | -$9.67 | -82.7% | $0.35B | $0.35B | -0.4% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -$3.29 | -$6.23 | -89.4% | $0.36B | $0.34B | +3.1% |
| ▼ Q2 FY2025 | May 15, 2025 | -$5.00 | -$6.28 | -25.6% | $0.37B | $0.35B | +6.7% |
| ▼ Q1 FY2025 | Mar 27, 2025 | -$8.50 | -$16.00 | -88.2% | $0.37B | $0.38B | -2.2% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -$1.50 | -$15.50 | -933.3% | $0.36B | $0.38B | -4.4% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$1.90
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Beat
EPS Actual
-$0.99
EPS Est.
-$4.85
EPS Surpr.
+79.6%
Revenue
$0.39B
Q1 FY2026
Mar 26, 2026Miss
EPS Actual
-$23.02
EPS Est.
-$8.06
EPS Surpr.
-185.5%
Revenue
$0.38B
Q4 FY2025
Nov 14, 2025Miss
EPS Actual
-$9.67
EPS Est.
-$5.29
EPS Surpr.
-82.7%
Revenue
$0.35B
Q3 FY2025
Aug 14, 2025Miss
EPS Actual
-$6.23
EPS Est.
-$3.29
EPS Surpr.
-89.4%
Revenue
$0.36B
Q2 FY2025
May 15, 2025Miss
EPS Actual
-$6.28
EPS Est.
-$5.00
EPS Surpr.
-25.6%
Revenue
$0.37B
Q1 FY2025
Mar 27, 2025Miss
EPS Actual
-$16.00
EPS Est.
-$8.50
EPS Surpr.
-88.2%
Revenue
$0.37B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
-$15.50
EPS Est.
-$1.50
EPS Surpr.
-933.3%
Revenue
$0.36B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2026 | $-4.07 | $-3.94 | $-3.81 | 1 |
| Q3 FY2026 | $-3.36 | $-2.77 | $-2.17 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.4B | $0.4B | $0.4B | 1 |
| Q3 FY2027 | $0.4B | $0.4B | $0.4B | 1 |
| Q2 FY2027 | $0.4B | $0.4B | $0.4B | 1 |
| Q1 FY2027 | $0.4B | $0.4B | $0.4B | 1 |
| Q4 FY2026 | $0.4B | $0.4B | $0.4B | 1 |
| Q3 FY2026 | $0.4B | $0.4B | $0.4B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 14, 2026 | +79.6% | $3.57 | $4.03 | +12.89% |
| ▼ Q1 FY2026 | Mar 26, 2026 | -185.5% | $3.11 | $2.79 | -10.29% |
| ▼ Q4 FY2025 | Nov 14, 2025 | -82.7% | $7.00 | $6.84 | -2.29% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -89.4% | $7.10 | $6.94 | -2.25% |
| ▼ Q2 FY2025 | May 15, 2025 | -25.6% | $8.18 | $8.30 | +1.47% |
| ▼ Q1 FY2025 | Mar 27, 2025 | -88.2% | $8.90 | $9.05 | +1.69% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -933.3% | $19.80 | $19.50 | -1.52% |
| ▼ Q3 FY2024 | Aug 7, 2024 | -87.5% | $30.30 | $30.80 | +1.65% |
Q2 FY2026+12.89%
Report Date
May 14, 2026
EPS Beat/Miss
+79.6%
Price Before
$3.57
Price After
$4.03
Q1 FY2026-10.29%
Report Date
Mar 26, 2026
EPS Beat/Miss
-185.5%
Price Before
$3.11
Price After
$2.79
Q4 FY2025-2.29%
Report Date
Nov 14, 2025
EPS Beat/Miss
-82.7%
Price Before
$7.00
Price After
$6.84
Q3 FY2025-2.25%
Report Date
Aug 14, 2025
EPS Beat/Miss
-89.4%
Price Before
$7.10
Price After
$6.94
Q2 FY2025+1.47%
Report Date
May 15, 2025
EPS Beat/Miss
-25.6%
Price Before
$8.18
Price After
$8.30
Q1 FY2025+1.69%
Report Date
Mar 27, 2025
EPS Beat/Miss
-88.2%
Price Before
$8.90
Price After
$9.05
Q4 FY2024-1.52%
Report Date
Nov 12, 2024
EPS Beat/Miss
-933.3%
Price Before
$19.80
Price After
$19.50
Q3 FY2024+1.65%
Report Date
Aug 7, 2024
EPS Beat/Miss
-87.5%
Price Before
$30.30
Price After
$30.80
Avg Beat Reaction+12.89%
Avg Miss Reaction-1.65%
Beat Rate1 / 8 quarters
Largest Move+12.89% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PIII ends December
P3 Health Partners Inc. (PIII) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-0.99 — beating the analyst consensus of $-4.85 by +79.6%. The next PIII earnings date is expected around September 1, 2026.
Each quarter, investors track PIII earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PIII revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PIII's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PIII earnings · 5 questionsP3 Health Partners Inc.'s next earnings report is expected around September 1, 2026. PIII typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PIII historically reports after market close (AMC).
PIII earnings datewhen is PIII earningsPIII next earnings datewhen does PIII report earningsPIII earnings calendar
▸ Source: FMP · P3 Health Partners Inc. SEC filings · US GAAP · P3 Health Partners Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026